BACKGROUND: Despite its accessible superficial location, the indication for surgical evacuation in cases of lobar intracerebral hemorrhage (LICH) suspected to be related to cerebral amyloid angiopathy (CAA) is controversial because of advanced patient age and concerns about postoperative hemostasis. OBJECTIVE: To examine factors associated with postoperative outcome in CAA-related LICH. METHODS: Review of consecutive patients with pathologically proven CAA who underwent LICH evacuation at Saint Marys Hospital, Rochester, Minnesota, between 1987 and 2006 . End points were length of stay and postoperative outcome at discharge and last follow-up using the Glasgow Outcome Scale. We also performed a systematic review of all published studies evaluating the outcome of surgically treated CCA-related LICH published between 1984 and 2010. RESULTS: We identified 23 patients with CAA-related LICH treated surgically. Favorable outcome (Glasgow Outcome Scale .3) at discharge was noted in 5 patients (22%), and at 6-to 12-month follow-up (n = 15) in 7 patients (47%). Three (13%) died in the hospital, including 1 of 4 patients with postoperative hemorrhage. Intraventricular hemorrhage (IVH) was associated with poor outcome at discharge. Older age ($75 years), history of hypertension, and degree of preoperative midline shift were associated with more prolonged length of stay. In our systematic review, we identified 14 studies including 278 cases. Overall mortality rate was 25%, and poor postoperative outcome was associated with older age, IVH, and preoperative dementia. CONCLUSION: Neurosurgical evacuation may be performed with acceptable safety in patients with CAA-related LICH. A systematic literature review indicates that older age, preexistent dementia, and presurgical IVH portend poor postoperative outcome.
C erebral amyloid angiopathy (CAA), also known as cerebral congophilic angiopathy or cerebral amyloidosis, is a frequent cause of intracerebral hemorrhage (ICH). CAA-related ICH has a strong lobar predilection, occurring most often in temporal and occipital lobes. 1, 2 Patients with CAA-related ICH have a lower mortality rate, but a greater risk of recurrence than other types of ICH. Recurrent hemorrhages can occur in as many as 38% of patients with CAA within 1.5 years after the first hemorrhage. [3] [4] [5] The annual risk of recurrent hemorrhage is 10.5%. 6, 7 Recurrence of lobar intracerebral hemorrhage (LICH) is associated with greater disability and increased mortality. 4 CAA-related ICH is an important cause of morbidity and mortality in normotensive elderly patients. The diagnosis of CAA-related ICH can only be definitely established by the histological identification of amyloid protein deposits in the walls of cortical and leptomeningeal vessels. 8 However, CAA can be suspected in elderly patients presenting with LICH, especially if the LICH is recurrent or there is evidence of cortical microhemorrhages on brain magnetic resonance imaging. 9 Subgroup analysis of the International Surgical Trial in ICH (STICH) showed that patients with superficial hematomas could benefit from surgical evacuation. 10 Yet, despite their superficial location, neurosurgeons are often reluctant to operate on patients with suspected CAA-related hematomas. In part, this is because patients are often very old and cognitively impaired. In addition, some early small series reporting poor postoperative outcomes led to the opinion that hematoma evacuation in patients with CAA was dangerous because of uncontrollable intraoperative bleeding and recurrent postoperative hemorrhage, [11] [12] [13] [14] which could be fatal. 15 However, some other studies later showed that surgical evacuation could actually be accomplished with adequate intraoperative hemostasis and low risk of postoperative hemorrhage and also reported a higher rate of favorable postoperative outcomes. [16] [17] [18] [19] The factors associated with outcome in patients who undergo surgical evacuation of CAA-related LICH remain insufficiently known.
In this study, we analyzed our experience with surgical treatment of patients with pathologically proven CAA-related LICH and combined our results with those of a systematic analysis of all previously published series on this topic. The aim of our study was to elucidate which factors are associated with postoperative outcome and length of hospitalization in these patients.
METHODS
The design of our study was approved by our institutional review board. Using our electronic search system (search terms: cerebral amyloid angiopathy, craniotomy, intracerebral hemorrhage), we identified all consecutive patients with CAA-related LICH who underwent craniotomy and hematoma evacuation in Saint Marys Hospital, Rochester, Minnesota, between 1987 and 2006. All patients had confirmed histological diagnosis of CAA by immunohistochemistry (Congo-red staining) of the surgical sample.
From patients' medical records, we collected each patient's sex and age, presurgical Glasgow Coma Scale (GCS), 20 presence of hemiparesis, history of dementia, history of hypertension, use of antihypertensive medications, history of diabetes mellitus, any systemic bleeding tendency (defined as international normalized ratio .1.4; thrombocytopenia ,100 000), use of anticoagulant or antiplatelet agents, and history of previous LICH. From the preoperative computed tomography (CT) scans, we evaluated the location, number (if multiple), volume, and shape (lobular, round, irregular) of the hematomas. Hematoma volume was graded as small (,30 mL), medium ($30 mL and ,60 mL), or large ($60 mL). The presence of preoperative intraventricular hemorrhage (IVH), subarachnoid hemorrhage (SAH), and midline shift of the septum pellucidum was also noted. Postoperative hemorrhage, defined as any new additional ICH confirmed by postoperative CT scan within 48 hours after neurosurgery, 17 was evaluated by hematoma volume. Evidence of progressive ventricular dilatation was assessed by comparison of preoperative and postoperative CT scans.
The surgical details examined comprised the surgical techniques used to evacuate the hematoma, any description in the operative report of difficulty to achieve intraoperative hemostasis, administration of thrombotic agents during the operation, and the time between hemorrhage onset and hematoma evacuation.
Fifteen patients were followed up from 6 to 12 months postoperatively. The outcome was classified according to the Glasgow Outcome Scale (GOS) 21 : 1, dead; 2, vegetative state; 3, severely disabled; 4, moderately disabled; and 5, good recovery.
We then proceeded to perform a systematic review of the literature to identify all published studies reporting on surgically treated patients with CAA-related LICH. Using the PubMed engine, we conducted a search of the following combined terms: cerebral amyloid angiopathy, intracerebral hemorrhage, and surgery. We only included surgical series with available information on postsurgical functional outcome and excluded case series reporting fewer than 5 cases to avoid possible case selection bias. We identified 14 studies published between 1984 and 2010 reporting on a total of 278 patients. We gathered all clinical and radiological data reported in those studies and combined the information with that of our series.
For statistical analysis, the postoperative outcome was categorized into 2 groups: good (GOS .3) and poor (GOS #3) outcome. We used the Fisher exact test to perform the univariate analyses aimed at identifying the clinical factors associated with postoperative outcome. We used analysis of variance to identify the clinical factors associated with the length of stay (LOS).
RESULTS
We identified 23 patients with CAA-related LICH treated with surgery at our hospital. There were 14 women (61%). Ages ranged from 61 to 85 years (mean age, 73.2 6 6 years). Twelve patients (52%) were older than 75 years. Eleven patients (48%) presented with hemiparesis. Four patients (17%) had been previously diagnosed with dementia. Thirteen patients (57%) had a history of hypertension, and 10 patients (43%) were taking antihypertensive agents. Four patients (17%) had a history of diabetes mellitus. Six patients (26%) had laboratory results indicative of bleeding tendency. Nine patients (39%) were taking antiplatelet agents, and 5 patients (22%) were taking anticoagulant agents at the time of LICH onset. Two patients (9%) had a history of a previous LICH.
Preoperative CT scans showed multiple lobar hemorrhages in 4 patients (17%). Nine patients (39%) had LICH in the dominant hemisphere. Ten (43%) hematomas were located in the frontal lobe, 5 (22%) in the temporal lobe, 5 (22%) in the parietal lobe, and 3 (13%) in the occipital lobe. Hematoma volume was small in 5 (22%), medium in 8 (35%), and large in 10 (43%). Hematoma shape was lobular in 10 (43%), irregular in 10 (43%), and rounded in 3 (13%). Ten (43%) CAA-related LICHs were associated with IVH. Four patients (17%) had progressive ventricular dilatation. Eleven patients (48%) had SAH. Twenty-two patients (96%) had midline shift.
All hematoma evacuations were performed by means of craniotomy. Two patients had ventriculostomy. Twenty patients (87%) had surgery within 48 hours after symptom onset. Twelve patients (52%) were given a thrombotic agent during the operation. Four patients (17%) had documented postoperative hemorrhage. The sizes of these postoperative hematomas were 1 cm 3 , 10 cm 3 , 29 cm 3 , and 32.8 cm 3 . One patient required a second evacuation.
The postoperative outcome was good at discharge in 5 patients (22%) and at 6-to 12-month follow-up (n = 15) in 7 patients (47%). IVH was associated with poor outcome at discharge (Table 1) . No patients with initial coma (GCS #8) had recovered good function upon discharge, but delayed recovery was possible. The mean hospital LOS after surgery was 18.5 6 10.6 days. Age, history of hypertension, and midline shift were associated with longer hospital LOS. Three patients (13%) died in the hospital after the surgical treatment. Their ages were 70, 70, and 61 years. Initial GCS scores were 8, 12, and 4. All of these patients were on antiplatelet agents and presented with large hematomas, midline shift, IVH, and SAH. During the surgical intervention, they all had poor intraoperative hemostasis requiring administration of a thrombotic agent. One patient had rebleeding after the first hematoma evacuation.
The pertinent studies identified by our systematic review of the literature are displayed in Table 2 . Adding the 278 cases reported in these 14 studies to our 23 cases, we included 301 cases in our combined analysis. Overall, the mortality rate was 25% in this combined cohort. Good outcome was observed in 26% of patients in whom functional outcome was reported. Older age, IVH, and history of dementia were associated with poor postoperative outcome (Table 3) .
DISCUSSION
In this study, we analyzed our experience with surgical treatment of LICH related to CAA and included our results in a pooled analysis of case series published in the literature that fulfilled our inclusion criteria to evaluate which factors are associated with postoperative outcome in these patients. Our findings indicate that advanced age, preexistent dementia, and preoperative IVH are the variables most strongly associated with poor outcome after surgery. Overall, mortality is not very high (13% in our series and 25% in the combined cohort compared with 36% in the surgical arm of STICH), 10 but good functional recovery is infrequent (22% in our series and 26% in the combined cohort, which is similar to the rates of 26% and 24% in the surgical and initial conservative treatment arms of STICH). 10 Our results suggest that it may be most prudent to treat elderly patients ($75 years) with CAA-related LICH conservatively. Assessment of previous cognitive function should be part of the evaluation for possible surgical candidates because patients with previous evidence of dementia fare poorly despite surgery. These are important considerations because CAA is most severe in the very elderly, and its progression is associated with the development of dementia. 11, 22 We found that IVH was a consistently strong risk factor for an adverse postoperative outcome. Although IVH may worsen prognosis in itself, 23 it is also possible that secondary IVH from CAA-related LICH reflects more extensive parenchymal damage because only the larger lobar hematomas invade the ventricular system. Lack of details in the published data impeded us from determining precise hematoma volumes and degrees of midline shift in our pooled population. These limitations might explain why these other indicators of larger hematoma size were not significantly associated with poor outcome as opposed to IVH, which was more consistently reported.
Intraoperative hemostasis was adequate in most patients of our series, but intra-and postoperative bleeding led to poor clinical results. We could not find sufficient information in previous studies to confirm or refute this information. The determinants of poor intraoperative hemostasis and recurrent postoperative hemorrhage in CAA are not well elucidated, but genetic factors may play an important role. Carriers of the apolipoprotein E epsilon 2/epsilon 4 polymorphism may have higher risk of LICH recurrence. 6 The apolipoprotein epsilon 2 allele has been associated with multiple CAA-related hematomas. 24, 25 Some evidence support the hypothesis that apolipoprotein epsilon 2 makes blood vessels with amyloid deposition more prone to rupture and might worsen intraoperative hemostasis. 26 The overall risk of recurrent hemorrhage is probably influenced by an interaction between genetic predisposition, comorbid conditions, and extrinsic factors, such as hypertension, diabetes mellitus, or use of antiplatelet agents. In fact, all the patients who had postoperative hemorrhages in our series had been on antiplatelet therapy before LICH onset. Patients with LICH who carry the apolipoprotein E epsilon 2 or 4 alleles have been reported to have increased risk of recurrent hemorrhage. 6 We did not have information on apolipoprotein E genotype in our patients.
The main limitation of our case series lies in the relatively small size of our cohort, which probably reflects very careful patient selection for surgery. Lack of statistical power prevented us from being able to perform a multivariate analysis. Five patients were lost to follow-up, which further limited our late-outcome analysis. Meanwhile, our retrospective review was limited by the inconsistent report of specific clinical and radiological variables and the use of different measures of functional outcome across the various studies. Sometimes even when a variable was reported in a study, the lack of raw data and the use of different dichotomization cut points made it impossible for us to include that information in the pooled analysis. Discrepancies in the results of the analysis of our series and the combined cohort might be explained by these limitations. Variables associated with poor outcome in the pooled analysis (such as older age and previous dementia) may not have been significant in our series because of insufficient statistical power and selection bias (eg, frailer and cognitively impaired elderly patients may not have been offered surgery). Finally, the results of our systematic review may have been affected by publication bias. Most studies were conducted at large institutions of developed countries; we cannot be certain about the applicability of our findings to other settings.
We conclude that surgical evacuation may be performed with acceptable safety in patients with CAA-related LICH. Based on our systematic review of the literature, and including our own experience, the risk factors for an adverse postoperative outcome include older age ($75 years), IVH, and dementia. These findings may help neurologists and neurosurgeons define which patients are the best surgical candidates. Discussions with patients and families before surgery should set realistic expectations because hematoma evacuation often prevents death, but infrequently leads to recovery of functional independence. 16, 17, 26, 27, 29, 32 Female (n = 59) 23 36 Male (n = 41) 18 23 .68 IVH (n = 170) 17, 18, 27, 32 No (n = 126) 36 90 Yes (n = 44) 4 40 .01 SAH (n = 72) 17, 27, 30 No (n = 22) 10 12 Yes (n = 50) 19 31 .60 Initial GCS (n = 142) 16, 18, 27, 32 .8 (n = 100) 19 81 #8 (n = 42) 25 36 .63 Size (n = 65) 17, 32 Small (n = 18) 7 11 .09 Medium (n = 24) 12 12 .44 Large (n = 13) 4 9 .09 Location (n = 98) 16, 17, 26, 27, 29, 32 Temporal (n = 18) 9 9 .29 Occipital (n = 18) 9 9 .29 Frontal (n = 33) 13 20 1.00 Parietal (n = 29) 9 20 .37 History of LICH (n = 74) 14, 16, 17 No (n = 59) 28 31 Yes (n = 15) 4 11 .24 Postoperative hemorrhage (n = 84) 14, 17, 29, 30, 32 No (n = 66) 30 36 Yes (n = 18) 4 14 .37 Hypertension history (n=85) 14, 16, 17, 27, 32 No (n = 52) 25 27 Yes (n = 33) 11 22 .26 Dementia (n = 85) 14, 16, 17, 27, 32 No (n = 71) 34 37 Yes (n = 14) 2 12 .04 a CAA, cerebral amyloid angiopathy; ICH, intracerebral hemorrhage; GOS, Glasgow Outcome Scale; GCS, Glasgow Coma Scale; LICH, lobar intracerebral hemorrhage; IVH, intraventricular hemorrhage; SAH, subarachnoid hemorrhage.
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